Position in MRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$5,990,670
+$211,337 QoQ
Shares Held
46,620
-3.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#960
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CULLINAN ASSOCIATES INC holds $90,482,569 across 10 Drug Manufacturers - General names. MRK ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
177,028 | $44,959,801 | |
| 2 | ABBV |
AbbVie Inc.
|
68,800 | $17,312,832 | |
| 3 | AMGN |
Amgen Inc
|
24,288 | $8,795,170 | |
| 4 | LLY |
ELI LILLY & Co
|
6,866 | $8,235,287 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
46,620 | $5,990,670 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
40,190 | $2,315,747 | |
| 7 | PFE |
Pfizer Inc
|
51,301 | $1,235,328 | |
| 8 | NVS |
Novartis AG
|
4,700 | $736,584 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,990,670 | 46,620 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $5,779,333 | 48,045 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $5,319,208 | 50,534 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $4,164,942 | 49,624 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,925,861 | 49,594 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $4,067,833 | 45,319 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $4,464,463 | 44,878 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $5,254,194 | 46,268 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,443,238 | 43,968 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $5,310,723 | 40,248 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $6,429,890 | 58,979 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $6,718,825 | 65,263 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $8,278,540 | 71,744 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $8,175,645 | 76,846 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $6,295,524 | 56,742 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $4,634,892 | 53,819 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $4,243,325 | 46,543 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $4,265,205 | 51,983 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $3,258,962 | 42,523 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $8,317,155 | 110,733 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $8,693,052 | 111,779 | Shares | Sole | 2021-07-07 | |
| 2021-03-31 | $9,850,488 | 127,779 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $10,483,810 | 128,164 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $10,325,703 | 124,481 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $7,493,744 | 96,906 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $8,326,904 | 108,226 | Shares | Sole | 2020-04-01 | |
| No filing history on record for this holder in this stock. | ||||||